Analyst · Axsome Therapeutics, Inc. (AXSM) | Ratings, Price Targets & Consensus

Analyst Consensus

Buy46 analysts

Buy

Updated Aug 6, 2026

Total Analysts46

Buy

25

Hold

1

Ratings

Updated Aug 6, 2026

Overall Rating

C-

DCF Score3.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$210.13

Median Target+13.14%

$237.74

Potential upside vs current price

Current Stock Price

$210.13

Median Target+13.14%

$237.74

Potential upside vs current price

Analyst Consensus

Buy46 analysts

Buy

Updated Aug 6, 2026

Total Analysts46

Buy

25

Hold

1

Ratings

Updated Aug 6, 2026

Overall Rating

C-

DCF Score3.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$210.13

Median Target+13.14%

$237.74

Potential upside vs current price

Current Stock Price

$210.13

Median Target+13.14%

$237.74

Potential upside vs current price